Miriam Pomeranz is a Dermatology physician affiliated with NYU Langone Health. OpenAlex indexes 147 publications with 2,461 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
530 1st Ave
New York, NY 100166402
Telephone
212-263-8243Provider last certified this registry record 23 Mar 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- ABBVIE INC.Program year20231 payment
- Amgen Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
37.5%Corticosteroid33.2%Triamcinolone Acetonide73%Fluocinolone Acetonide22%Halobetasol Propionate6%Part D<11 patientsRetinoid2.3%Acitretin100%Part D<11 patients+ 1 more class in this area
Sensory organs
21.5%Corticosteroid21.5%Clobetasol Propionate60%Hydrocortisone21%Betamethasone Dipropionate19%Part D<11 patientsAnti-infectives
20.7%Azole Antifungal16.8%Ketoconazole59%Fluconazole41%Part D≥28 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.8%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dental dams in dermatology: An underutilized barrier method of protection
International Journal of Women’s Dermatology
2022 - Chronic lymphocytic leukemia and the skin: implications for the dermatologist
International Journal of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”